Certified by Founder Lodge
Biolexis Therapeutics, Inc.
United States - Salt Lake City, UT
START UP
1 Disclosed Funding Rounds $10,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Moleculern™ – The Next Evolution in Drug Discovery
Screening each Moleculern™ fragment against a curated protein target library has resulted in 600K real/empirical data points and scaffold
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 30 ,2023 | Series A | $10,000,000 |
Clarke Capital Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
OneChronos | $32,000,000 | (Nov 20, 2024)
Kalder | $10,500,000 | (Nov 20, 2024)
Jimini Health | $8,000,000 | (Nov 20, 2024)
RIIG | $3,000,000 | (Nov 20, 2024)
EarthOptics | $24,000,000 | (Nov 20, 2024)
